关于牙膏功效及功效型牙膏的专家共识

2017-09-20 中华口腔医学会 中华口腔医学杂志.2017,52(9):524-528.

由中华口腔医学会口腔预防医学专业委员会、中华预防医学会口腔卫生保健专业委员会及四川大学口腔疾病研究国家重点实验室口腔健康研究室的相关专家共同组成的专家组,经过多次研讨并在广泛听取意见的基础上修订后形成此共识。

中文标题:

关于牙膏功效及功效型牙膏的专家共识

发布机构:

中华口腔医学会

发布日期:

2017-09-20

简要介绍:

由中华口腔医学会口腔预防医学专业委员会、中华预防医学会口腔卫生保健专业委员会及四川大学口腔疾病研究国家重点实验室口腔健康研究室的相关专家共同组成的专家组,经过多次研讨并在广泛听取意见的基础上修订后形成此共识。

 

拓展指南:口腔相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=关于牙膏功效及功效型牙膏的专家共识)] GetToolGuiderByIdResponse(projectId=1, id=193541c001500ef2, title=关于牙膏功效及功效型牙膏的专家共识, enTitle=, guiderFrom=中华口腔医学杂志.2017,52(9):524-528., authorId=null, author=, summary=由中华口腔医学会口腔预防医学专业委员会、中华预防医学会口腔卫生保健专业委员会及四川大学口腔疾病研究国家重点实验室口腔健康研究室的相关专家共同组成的专家组,经过多次研讨并在广泛听取意见的基础上修订后形成此共识。 , cover=, journalId=null, articlesId=null, associationId=232, associationName=中华口腔医学会, associationIntro=中华口腔医学会是口腔医学科学技术工作者自愿结成的全国性学术性群众团体,为非营利性社会组织,是依法成立的社团法人,是政府联系口腔医学科学技术工作者的纽带和桥梁,是发展我国口腔医学科学的社会力量。学会成立于1996年11月7日,她的前身是1951年成立的中华医学会口腔科学会。 学会成立以来,全国各省市的口腔分会亦争取从省、直辖市医学会中独立出来,成立省、直辖市口腔医学会。省市口腔医学会一成立即成为中华口腔医学会的团体会员,除对学会有业务指导关系外,尚的对团体会员的领导作用。, copyright=0, guiderPublishedTime=Wed Sep 20 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>由中华口腔医学会口腔预防医学专业委员会、中华预防医学会口腔卫生保健专业委员会及四川大学口腔疾病研究国家重点实验室口腔健康研究室的相关专家共同组成的专家组,经过多次研讨并在广泛听取意见的基础上修订后形成此共识。 </P> <P> </P>拓展指南:<strong>与<font color=red>口腔</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=df16b1c001a84470" title="口腔美学临床摄影专家共识" target=_blank>口腔美学临床摄影专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=4fa991c00130a2e2" title="2015 NICE指南:促进口腔健康(NG.30)" target=_blank>2015 NICE指南:促进口腔健康(NG.30)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b4b181c00129e1f6" title="2016 NICE指南:护理院内成人口腔健康(NG.48)" target=_blank>2016 NICE指南:护理院内成人口腔健康(NG.48)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=bcd281c00121e6a0" title="2015 ESMO临床实践指南:口腔和胃肠道粘膜损伤的诊断,治疗和随访" target=_blank>2015 ESMO临床实践指南:口腔和胃肠道粘膜损伤的诊断,治疗和随访</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=558de1c00116321a" title="2010口腔科10个病种临床路径" target=_blank>2010口腔科10个病种临床路径</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%8F%A3%E8%85%94" target=_blank>有关口腔更多指南</a></ul>, tagList=[TagDto(tagId=59874, tagName=牙膏功效), TagDto(tagId=59875, tagName=功效型牙膏)], categoryList=[CategoryDto(categoryId=31, categoryName=口腔科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8481, appHits=293, showAppHits=0, pcHits=6747, showPcHits=2232, likes=190, shares=8, comments=6, approvalStatus=1, publishedTime=Wed Sep 27 12:39:46 CST 2017, publishedTimeString=2017-09-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Sep 27 12:39:46 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:20:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=关于牙膏功效及功效型牙膏的专家共识)])
关于牙膏功效及功效型牙膏的专家共识
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1010295, encodeId=43b810102951d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfed5581097, createdName=陈姗, createdTime=Sun Aug 22 14:52:45 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922368, encodeId=af76922368ea, content=太棒啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=15685458283, createdName=ms5000001620305914, createdTime=Wed Feb 03 08:40:47 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274722, encodeId=d0ee2e472242, content=赞!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZwuNTqgiaD8tEoqIF6iaTiasqka2cLqyByM3WCeZZnx7NV8r8wTqn2sf99wzIgUEajeMZ1cXxubsKA/0, createdBy=80322236647, createdName=李淡淡, createdTime=Tue Jan 02 12:05:32 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248221, encodeId=59782482216c, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/d95fde48d2044f401185c488baba9736.jpg, createdBy=ac6c78427, createdName=test1797, createdTime=Wed Sep 27 17:02:34 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2021-08-22 陈姗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1010295, encodeId=43b810102951d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfed5581097, createdName=陈姗, createdTime=Sun Aug 22 14:52:45 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922368, encodeId=af76922368ea, content=太棒啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=15685458283, createdName=ms5000001620305914, createdTime=Wed Feb 03 08:40:47 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274722, encodeId=d0ee2e472242, content=赞!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZwuNTqgiaD8tEoqIF6iaTiasqka2cLqyByM3WCeZZnx7NV8r8wTqn2sf99wzIgUEajeMZ1cXxubsKA/0, createdBy=80322236647, createdName=李淡淡, createdTime=Tue Jan 02 12:05:32 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248221, encodeId=59782482216c, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/d95fde48d2044f401185c488baba9736.jpg, createdBy=ac6c78427, createdName=test1797, createdTime=Wed Sep 27 17:02:34 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2021-02-03 ms5000001620305914

    太棒啦

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1010295, encodeId=43b810102951d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfed5581097, createdName=陈姗, createdTime=Sun Aug 22 14:52:45 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922368, encodeId=af76922368ea, content=太棒啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=15685458283, createdName=ms5000001620305914, createdTime=Wed Feb 03 08:40:47 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274722, encodeId=d0ee2e472242, content=赞!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZwuNTqgiaD8tEoqIF6iaTiasqka2cLqyByM3WCeZZnx7NV8r8wTqn2sf99wzIgUEajeMZ1cXxubsKA/0, createdBy=80322236647, createdName=李淡淡, createdTime=Tue Jan 02 12:05:32 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248221, encodeId=59782482216c, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/d95fde48d2044f401185c488baba9736.jpg, createdBy=ac6c78427, createdName=test1797, createdTime=Wed Sep 27 17:02:34 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2018-01-02 李淡淡

    赞!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1010295, encodeId=43b810102951d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfed5581097, createdName=陈姗, createdTime=Sun Aug 22 14:52:45 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922368, encodeId=af76922368ea, content=太棒啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=15685458283, createdName=ms5000001620305914, createdTime=Wed Feb 03 08:40:47 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274722, encodeId=d0ee2e472242, content=赞!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJZwuNTqgiaD8tEoqIF6iaTiasqka2cLqyByM3WCeZZnx7NV8r8wTqn2sf99wzIgUEajeMZ1cXxubsKA/0, createdBy=80322236647, createdName=李淡淡, createdTime=Tue Jan 02 12:05:32 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248221, encodeId=59782482216c, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/d95fde48d2044f401185c488baba9736.jpg, createdBy=ac6c78427, createdName=test1797, createdTime=Wed Sep 27 17:02:34 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2017-09-27 test1797

    0